BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14248694)

  • 1. [MUSCULAR DYSTROPHY OF THE DUCHENNE TYPE: ENZYMATIC ACTIVITY IN A FAMILIAL GROUP OF SUBJECTS WITH AND WITHOUT CLINICAL MANIFESTATIONS].
    MARZUOLI U; RUBINO R; BOCCALATTE G
    Minerva Med; 1965 Jan; 56():90-2. PubMed ID: 14248694
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF SERUM CREATINE PHOSPHOKINASE AND OTHER SERUM ENZYMES IN THE DIAGNOSIS OF PROGRESSIVE MUSCULAR DYSTROPHY.
    SWAIMAN KF; SANDLER B
    J Pediatr; 1963 Dec; 63():1116-9. PubMed ID: 14089817
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. I. SERUM ENZYMES IN PROGRESSIVE MUSCULAR DYSTROPHY (TYPE I, II, IIIA)].
    ROTTHAUWE HW; KOWALEWSKI S
    Klin Wochenschr; 1965 Feb; 43():144-50. PubMed ID: 14258511
    [No Abstract]   [Full Text] [Related]  

  • 4. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. I. MUSCULAR DYSTROPHY.
    FOWLER WM
    Arch Phys Med Rehabil; 1964 Mar; 45():117-24. PubMed ID: 14127953
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICAL AND BIOCHEMICAL STUDIES IN MYOPATHIES. 3. RECESSIVE X-CHROMOSOMAL MUSCULAR DYSTROPHY WITH RELATIVELY BENIGN COURSE].
    ROTTHAUWE HW; KOWALEWSKI S
    Klin Wochenschr; 1965 Feb; 43():158-63. PubMed ID: 14258512
    [No Abstract]   [Full Text] [Related]  

  • 6. THE CLINICAL BIOCHEMISTRY OF THE MUSCULAR DYSTROPHIES.
    THOMSON WH
    Adv Clin Chem; 1964; 7():137-97. PubMed ID: 14264721
    [No Abstract]   [Full Text] [Related]  

  • 7. The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy.
    Thomson WH
    Clin Chim Acta; 1969 Nov; 26(2):207-21. PubMed ID: 5352692
    [No Abstract]   [Full Text] [Related]  

  • 8. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. II. NEUROLOGIC DISEASES OTHER THAN MUSCULAR DYSTROPHY.
    FOWLER WM; PEARSON CM
    Arch Phys Med Rehabil; 1964 Mar; 45():125-30. PubMed ID: 14127954
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
    Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):92-115. PubMed ID: 5800957
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy.
    Griffiths PD
    Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign congenital muscular dystrophy: a special form of congenital hypotonia.
    Zellweger H; Afifi A; McCormick WF; Mergner W
    Clin Pediatr (Phila); 1967 Nov; 6(11):655-63. PubMed ID: 6058423
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme activity determination in progressive muscular dystrophy. IV. Serum enzymatic kinetics in the preclinical stage of the Duchenne type during the 1st 2 years of life].
    Heyck H; Laudahn G; Carsten PM
    Klin Wochenschr; 1966 Jun; 44(12):695-700. PubMed ID: 5990806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological anomalies in the apparently healthy transmitters of muscular dystrophy].
    DEMOS J; DREYFUS JC; SCHAPIRA F; SCHAPIRA G
    Rev Can Biol; 1962; 21():587-97. PubMed ID: 14026924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYOPATHIC CHANGES IN A MUSCULAR DYSTROPHY CARRIER.
    DUBOWITZ V
    J Neurol Neurosurg Psychiatry; 1963 Aug; 26(4):322-5. PubMed ID: 14043046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.